Vascular Solutions Reports Third Quarter Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/13/2026
- Wall Street ends higher as SpaceX's market debut dominates
- SpaceX prices historic IPO at $135/share in largest ever new listing
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- UBS cuts gold price forecasts on delayed Fed easing outlook
- Brent falls to lowest since March on expected peace deal
- NASDAQ adds five companies to NASDAQ-100 index in quarterly rebalance
- Super Micro Computer establishes $1.25 billion stock sale agreement
- Wall Street ends higher as SpaceX's market debut dominates
- 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
- SpaceX Shares Indicated To Open At $155
Vascular Solutions (VASC) '3-for-3' in 2015; Canaccord Genuity Reiterates Buy
October 21, 2015 11:07 AM EDTCanaccord Genuity reiterated a Buy rating and $41.50 price target on Vascular Solutions (NASDAQ: VASC), following the company's 3Q15 earnings results. VASC reported its 3rd straight quarter beat and raise in 2015, beating consensus' EPS by $0.02.
Analyst Jason Mills commented, "In terms of a beat and raise batting average,... More
Vascular Solutions (VASC) Tops Q3 EPS by 2c; Boosts FY15 Outlook
October 20, 2015 4:07 PM EDTVascular Solutions (NASDAQ: VASC) reported Q3 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $37 million versus the consensus estimate of $36.41 million.
Vascular Solutions sees FY2015 EPS of $1.03-$1.05, versus the consensus of $1.03. Vascular Solutions sees FY2015... More
